amlodipine and olmesartan medoxomil
Generic: amlodipine and olmesartan medoxomil
Labeler: micro labs limitedDrug Facts
Product Profile
Brand Name
amlodipine and olmesartan medoxomil
Generic Name
amlodipine and olmesartan medoxomil
Labeler
micro labs limited
Dosage Form
TABLET
Routes
Active Ingredients
amlodipine besylate 5 mg/1, olmesartan medoxomil 40 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42571-237
Product ID
42571-237_2b531912-67b1-6172-e063-6394a90a178f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207435
Listing Expiration
2026-12-31
Marketing Start
2018-01-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42571237
Hyphenated Format
42571-237
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
amlodipine and olmesartan medoxomil (source: ndc)
Generic Name
amlodipine and olmesartan medoxomil (source: ndc)
Application Number
ANDA207435 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 40 mg/1
Packaging
- 500 TABLET in 1 BOTTLE (42571-237-05)
- 1000 TABLET in 1 BOTTLE (42571-237-10)
- 30 TABLET in 1 BOTTLE (42571-237-30)
- 90 TABLET in 1 BOTTLE (42571-237-90)
Packages (4)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2b531912-67b1-6172-e063-6394a90a178f", "openfda": {"upc": ["0342571238308", "0342571237301", "0342571235307", "0342571236304"], "unii": ["864V2Q084H", "6M97XTV3HD"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_set_id": ["7fcf6a87-7b3e-4cef-8c47-c8a008cfea82"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (42571-237-05)", "package_ndc": "42571-237-05", "marketing_start_date": "20180101"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (42571-237-10)", "package_ndc": "42571-237-10", "marketing_start_date": "20180101"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (42571-237-30)", "package_ndc": "42571-237-30", "marketing_start_date": "20180101"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (42571-237-90)", "package_ndc": "42571-237-90", "marketing_start_date": "20180101"}], "brand_name": "AMLODIPINE AND OLMESARTAN MEDOXOMIL", "product_id": "42571-237_2b531912-67b1-6172-e063-6394a90a178f", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "42571-237", "generic_name": "Amlodipine and Olmesartan Medoxomil", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMLODIPINE AND OLMESARTAN MEDOXOMIL", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA207435", "marketing_category": "ANDA", "marketing_start_date": "20180101", "listing_expiration_date": "20261231"}